3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
22
Neoplasms
13
Colonic Neoplasms
10
Breast Neoplasms
10
Venous Thromboembolism
8
Prostatic Neoplasms
8
Multiple Myeloma
7
Recurrence
6
Polycythemia Vera
6
Carcinoma, Non-Small-Cell Lung
6
Thrombocythemia, Essential
4
Neoplasms, Plasma Cell
4
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Melanoma
3
Thrombosis
2
Sarcoma
2
Rectal Neoplasms
2
Primary Myelofibrosis
2
Pancreatic Neoplasms
2
Neoplastic Cells, Circulating
2
Neoplasms by Site
2
Myocardial Infarction
2
Lung Neoplasms
2
Intestinal Neoplasms
2
Intestinal Diseases
2
Inflammation
2
Gastrointestinal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Interventions
Gemcitabine
406
Oxaliplatin
131
Fluorouracil
125
130-nm albumin-bound paclitaxel
108
Capecitabine
100
Albumin-Bound Paclitaxel
90
Leucovorin
88
Irinotecan
87
Radiotherapy
76
Radiosurgery
64
Taxes
63
Cisplatin
56
Erlotinib Hydrochloride
44
Drug Therapy
42
folfirinox
40
Magnetic Resonance Spectroscopy
39
pembrolizumab
35
Blood Specimen Collection
33
S 1 (combination)
31
Pancreaticoduodenectomy
31
Docetaxel
31
Nivolumab
30
Bevacizumab
30
Biopsy
26
Surgical Procedures, Operative
25
Cyclophosphamide
25
irinotecan sucrosofate
24
Specimen Handling
24
Radiation
22
Standard of Care
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Pancreatic Neoplasms
×
Aspirin
×
Clear all
NCT04245644
2024-03-12
CAOS
IRCCS San Raffaele
Unknown
800 enrolled
NCT05637567
2023-11-13
ASAP
German Cancer Research Center
Phase 2
Not yet recruiting
170 enrolled